Evidence map›Paper›PMID 40842585›Full record

ArticleFrontiers in oncology2025

A multi-data fusion deep learning model for prognostic prediction in upper tract urothelial carcinoma.

Hongdi Sun, Siping Chen, Yongxing Bao, Fengyan You, Honghui Zhu, Xin Yao, Lianguo Chen, Jiangwei Miao, Fanggui Shao, Xiaomin Gao and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hongdi Sun *Department of Hematology, The Third Clinical Institute Affiliated to Wenzhou Medical University (Wenzhou People's Hospital), Wenzhou, Zhejiang, China.
Siping Chen *Department of Urology, Rui'an People's Hospital, The Third Affiliated Hospital of the Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yongxing Bao *Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Fengyan YouDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Honghui ZhuDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xin YaoDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lianguo ChenDepartment of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jiangwei MiaoDepartment of Urology, Rui'an People's Hospital, The Third Affiliated Hospital of the Wenzhou Medical University, Wenzhou, Zhejiang, China.
Fanggui ShaoDepartment of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xiaomin GaoDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Binwei LinDepartment of Urology, Rui'an People's Hospital, The Third Affiliated Hospital of the Wenzhou Medical University, Wenzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Upper tract urothelial carcinoma (UTUC) is a rare but highly invasive urinary malignancy with a high postoperative recurrence rate. Methods: We retrospectively collected data from 133 UTUC patients who underwent radical nephroureterectomy between 2005 and 2017. Patients were divided into a training set (n=103) and a testing set (n=30). A multi-modal deep learning model named Multi-modal Image-Clinical Combination Classifier (MICC) was developed by integrating multi-phase contrast-enhanced CT imaging and clinical data. The model's prognostic performance was compared with two unimodal models-ImageNet (CT-based) and ClinicalNet (clinical data-based)-and traditional clinical parameters including pathological T stage. Feature importance was evaluated using SHapley Additive exPlanations (SHAP). Results: The MICC model achieved superior prognostic accuracy with AUCs of 0.918 and 0.895 in the training and testing sets, respectively, outperforming unimodal models. Classification metrics were robust, with accuracy of 0.854, sensitivity of 0.889, specificity of 0.836, negative predictive value (NPV) of 0.933, and positive predictive value (PPV) of 0.744. Precision-recall analysis confirmed strong identification of high-risk patients despite dataset imbalance. SHAP analysis highlighted that CT imaging features contributed most significantly to the model's predictions. Conclusion: Integrating multi-phase CT imaging with clinical data, the MICC model provides accurate prognostic prediction for UTUC patients. This approach has potential to assist clinicians in personalized risk stratification and treatment planning, ultimately improving patient outcomes.

Indexed as

artificial intelligenceclinical dataCT imagedeep learningmulti-phase contrast-enhanced CTprognostic indicatorsradiomicsupper tract urothelial carcinoma

Identifiers

PMID40842585
PMCPMC12364636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.